Review: taking Novolog and Levemir together


Summary

Drug interactions are reported among people who take Novolog and Levemir together. This review analyzes the effectiveness and drug interactions between Novolog and Levemir. It is created by eHealthMe based on reports of 1,305 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Novolog

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. (latest outcomes from Novolog 21,697 users)

Levemir

Levemir has active ingredients of insulin detemir. It is often used in type 2 diabetes. (latest outcomes from Levemir 5,101 users)

On Sep, 14, 2016

1,305 people who take Novolog, Levemir are studied.


Number of reports submitted per year:

Novolog and Levemir drug interactions.

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • hypoglycaemia
  • abasia
  • abnormal loss of weight
  • arthritis
  • benign prostatic hyperplasia
  • blood glucose increased
  • bursitis infective
  • cholelithiasis
  • decreased immune responsiveness
1 - 6 months:
  • hypoglycaemia
  • loss of consciousness
  • cholangitis
  • intervertebral disc protrusion
  • pericarditis
  • pharyngitis
  • pleurisy
  • rhinitis allergic
  • blood sodium decreased
  • hypoglycaemic unconsciousness
6 - 12 months:
  • cholangitis
  • foetal exposure during pregnancy
  • intervertebral disc protrusion
  • pericarditis
  • pharyngitis
  • pleurisy
  • rhinitis allergic
  • anaemia
  • blood alkaline phosphatase increased
  • blood glucose increased
1 - 2 years:
  • bladder cancer
  • cholangitis
  • haemorrhagic anaemia
  • international normalised ratio increased
  • intervertebral disc protrusion
  • liver function test abnormal
  • pericarditis
  • pharyngitis
  • pleurisy
  • rhinitis allergic
2 - 5 years:
  • bladder cancer
  • blood glucose increased
  • cellulitis
  • death
  • hypoglycaemic unconsciousness
  • vomiting
  • bladder cancer stage ii
  • blood glucose decreased
  • chronic kidney disease
  • diabetic ketoacidosis
5 - 10 years:
  • vitreous haemorrhage
  • vomiting
  • blood glucose increased
  • dyspnoea
  • diabetic ketoacidosis
  • haemorrhagic anaemia
  • neovascularisation
  • premature delivery
  • upper gastrointestinal haemorrhage
  • urine analysis abnormal
10+ years:
  • fall
  • pleural effusion
  • pulmonary embolism
  • subdural haematoma
not specified:
  • blood glucose increased
  • drug ineffective
  • fatigue
  • vomiting
  • nausea
  • hypoglycaemia
  • blood glucose decreased
  • dyspnoea
  • dizziness
  • anaemia

Most common drug interactions by gender *:

female:
  • blood glucose increased
  • vomiting
  • nausea
  • drug ineffective
  • dizziness
  • blood glucose decreased
  • dyspnoea
  • fatigue
  • hypoglycaemia
  • fall
male:
  • blood glucose increased
  • hypoglycaemia
  • anaemia
  • drug ineffective
  • fatigue
  • blood glucose decreased
  • pain in extremity
  • dyspnoea
  • malaise
  • nausea

Most common drug interactions by age *:

0-1:
  • foetal exposure during pregnancy
  • hypoglycaemia neonatal
  • jaundice neonatal
2-9:
  • pruritus generalised
  • skin mass
10-19:
  • vomiting
  • blood glucose increased
  • hypoglycaemia
  • bedridden
  • catatonia
  • chest pain
  • cough
  • depression
  • nausea
  • pulmonary embolism
20-29:
  • abortion spontaneous
  • cystic fibrosis
  • diabetic ketoacidosis
  • dizziness
  • fall
  • pneumonia
  • tachycardia
  • abdominal pain lower
  • abdominal pain upper
  • anaemia
30-39:
  • diabetic ketoacidosis
  • vomiting
  • neovascularisation
  • premature delivery
  • urine analysis abnormal
  • vitreous haemorrhage
  • blood glucose increased
  • diabetes mellitus inadequate control
  • anaemia
  • blood alkaline phosphatase increased
40-49:
  • vomiting
  • blood glucose increased
  • hypoglycaemia
  • malaise
  • nausea
  • diabetic ketoacidosis
  • diarrhoea
  • headache
  • hyperhidrosis
  • tremor
50-59:
  • blood glucose increased
  • vomiting
  • dyspnoea
  • drug ineffective
  • insomnia
  • pain in extremity
  • diabetes mellitus inadequate control
  • fatigue
  • malaise
  • nausea
60+:
  • blood glucose increased
  • hypoglycaemia
  • blood glucose decreased
  • drug ineffective
  • anaemia
  • fatigue
  • asthenia
  • nausea
  • dizziness
  • dyspnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Novolog and Levemir?

Can you answer these questions?

More questions for: Novolog, Levemir

You may be interested in these reviews

More reviews for: Novolog, Levemir

On eHealthMe, Novolog (insulin aspart recombinant) is often used to treat diabetes. Levemir (insulin detemir) is often used to treat type 2 diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.